Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001521536-13-000100
Filing Date
2013-02-08
Accepted
2013-02-08 11:37:40
Documents
8

Document Format Files

Seq Description Document Type Size
1 q1100954_s1a-biozone.htm S-1/A 1656128
2 q1100954_ex23-1.htm EX-23.1 8557
  Complete submission text file 0001521536-13-000100.txt   5064397

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE FILE bzne-20120930.xml EX-101.INS 413781
4 XBRL SCHEMA FILE bzne-20120930.xsd EX-101.SCH 42676
5 XBRL CALCULATION FILE bzne-20120930_cal.xml EX-101.CAL 43317
6 XBRL DEFINITION FILE bzne-20120930_def.xml EX-101.DEF 190303
7 XBRL LABEL FILE bzne-20120930_lab.xml EX-101.LAB 224558
8 XBRL PRESENTATION FILE bzne-20120930_pre.xml EX-101.PRE 253024
Mailing Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137 800-689-0930
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-176951 | Film No.: 13585530
SIC: 2834 Pharmaceutical Preparations